Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.
The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...
Pregnancy complicates a cancer diagnosis in many ways. So cancer treatment may need to be adjusted. Here’s what we know so ...
The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
In 2021, Kelli Sosa was diagnosed with ovarian cancer. While undergoing chemotherapy and surgeries, doctors determined that ...
Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...
More clinical trials offering cutting-edge cancer care in Lancaster County will be among the changes if Dr. Efrat Dotan meets ...
Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...
Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...
A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...
10h
The star shares the first symptom that led to his Stage 3 cancer diagnosis, how he's coping and why he wants others to be ...
When Ellie Wilcock was hit by sharp pains in her abdomen and sudden bouts of fatigue in 2022, she blamed it on a urinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback